Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Artara Therapeutics Inc (NQ: TARA )

1.690 +0.050 (+3.05%)
Streaming Delayed Price Updated: 2:10 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,553
Open 1.670
Bid (Size) 1.680 (1)
Ask (Size) 1.710 (2)
Prev. Close 1.640
Today's Range 1.670 - 1.740
52wk Range 1.620 - 4.180
Shares Outstanding 11,235,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
-39.64%
-39.64%
1 Month
-22.12%
-22.12%
3 Month
-30.17%
-30.17%
6 Month
-48.94%
-48.94%
1 Year
-50.07%
-50.07%

More News

Read More
Recap: Protara Therapeutics Q1 Earnings
Via Benzinga
Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
Via Benzinga
Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Protara Therapeutics: Q3 Earnings Insights
Via Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Recap: Protara Therapeutics Q4 Earnings
Via Benzinga
11 Things to Know About Protara Therapeutics as TARA Stock Soars on Big FDA News
Via InvestorPlace
Exposures Product Safety
Why Protara Therapeutics Stock Is Rising Today
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.